Animal Models of Schizophrenia

Schizophrenia: Third Edition

Volumn , Issue , 2011, Pages 462-481

  Lipska, Barbara K ^a   Gogos, Joseph A ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b Columbia University Medical School ^*  (United States)

Author keywords

Animal models of schizophrenia; Animal models of schizophrenia phenomena linked to dopamine; DISC1, susceptibility gene for major mental illness through a balanced chromosomal translocation; Drugs, that have emerged exerting antidopaminergic efficacy; Genetic architecture of complex psychiatric disorders as schizophrenia; Heterozygous DGCR8 deficient mice showing deficits in a working memory dependent learning task; Neurodevelopmental models models testing etiological theories; Novel approaches to modeling schizophrenia; Perinatal stress models consequences of stress for brain development, shaping adult behavioral responses

Indexed keywords

EID: 84856110163     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444327298.ch22     Document Type: Chapter

References (234)

1. Abi-Dargham, A., Gil, R., Krystal, J. et al.(1998) Increased striatal dopamine transmission in schizophrenia: confi rmation in a second cohort. American Journal of Psychiatry 155, 761-767.
2. Adams, W., Kendell, R.E., Hare, E.H.&Munk-Jorgensen, P. (1993) Epidemiological evidence that maternal infl uenza contributes to the aetiology of schizophrenia: an analysis of Scottish, English and Danish data. British Journal of Psychiatry 163, 522-534.
3. Akbarian, S., Bunney, W.E. Jr., Potkin, S.G. et al.(1993) Altered distribution of nicotinamide-adenine dinucleotide phosphate - diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Archives of General Psychiatry 50, 169-177.
4. Akbarian, S., Kim, J.J., Potkin, S.G. et al.(1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Archives of General Psychiatry 52, 258-266.
5. Akbarian, S., Sucher, N.J., Bradley, D. et al.(1996) Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. Journal of Neuroscience 16, 19-30.
6. Al-Amin, H.A., Weinberger, D.R.&Lipska, B.K.(2000) Exaggerated MK-801-induced motor hyperactivity in rats with the neonatal lesion of the ventral hippocampus. Behavioural Pharmacology 11, 269-278.
7. Al-Amin, H.A., Weickert, C.S., Lillrank, S.M., Weinberger, D.R.&Lipska, B.K.(2001) Delayed onset of enhanced MK-801 - induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus. Biological Psychiatry 49, 528-539.
8. Angrist, B.M.&Gershon, S.(1970) The phenomenology of experimentally induced amphetamine psychosis-preliminary observations. Biological Psychiatry 2, 95-107.
9. Anholt, R.R., Dilda, C.L., Chang, S. et al.(2003) The genetic architecture of odor-guided behavior in Drosophila: epistasis and the transcriptome. Nature Genetics 35, 180-184.
10. Anisman, H., Zaharia, M.D., Meaney, M.J.&Merali, Z.(1998) Do early-life events permanently alter behavioral and hormonal responses to stressors? International Journal of Developmental Neuroscience 16, 149-164.
11. Arguello, P.A.&Gogos, J.A.(2006) Modeling madness in mice: one piece at a time. Neuron 52, 179-196.
12. Arnold, S.E., Hyman, B.T., van Hoesen, G.W.&Damasio, A.R. (1991) Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Archives of General Psychiatry 48, 625-632.
13. Ashe, P.C., Chlan-Fourney, J., Juorio, A.V.&Li, X.M.(2002) Brain-derived neurotrophic factor (BDNF) mRNA in rats with neonatal ibotenic acid lesions of the ventral hippocampus. Brain Research 956, 126-135.
14. Austin, C.P., Ky, B., Ma, L., Morris, J.A. & Shughrue, P.J.(2004a) DISC1 (Disrupted in Schizophrenia-1) is expressed in limbic regions of the primate brain. Neuroreport 14, 951-954.
15. Austin, C.P., Ky, B., Ma, L., Morris, J.A.&Shughrue, P.J.(2004b) Expression of Disrupted-In-Schizophrenia-1, a schizophrenia - associated gene, is prominent in the mouse hippocampus throughout brain development. Neuroscience 124, 3-10.
16. Bachevalier, J., Alvarado, M.C.&Malkova, L.(1999) Memory and socioemotional behavior in monkeys after hippocampal damage incurred in infancy or in adulthood. Biological Psychiatry 46, 329-339.
17. Baddeley, A.(1992) Working memory. Science 255, 556-559.
18. Bakshi, V.P., Swerdlow, N.R., Braff, D.L. & Geyer, M.A.(1998) Reversal of isolation rearing-induced defi cits in prepulse inhibition by Seroquel and olanzapine. Biological Psychiatry 43, 436-445.
19. Bearden, C.E., Woodin, M.F., Wang, P.P. et al.(2001) The neurocognitive phenotype of the 22q11.2 deletion syndrome: selective defi cit in visual-spatial memory. Journal of Clinical and Experimental Neuropsychology 23, 447-464.
20. Beaulieu, J.M., Sotnikova, T.D., Marion, S., Lefkowitz, R.J., Gainetdinov, R.R.&Caron, M.G.(2005) An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122, 261-273.
21. Beauregard, M.&Bachevalier, J.(1996) Neonatal insult to the hippocampal region and schizophrenia: a review and a putative animal model. Canadian Journal of Psychiatry 41, 446-445.
22. Becker, A., Grecksch, G., Bernsteinn, H.G., Hollt, V.&Bogerts, B.(1999) Social behavior in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis. Psychopharmacology 144, 333-338.
23. Becker, A.&Grecksch, G.(2000) Social memory is impaired in neonatally ibotenic acid lesioned rats. Behavioural Brain Research 109, 137-140.
24. Bender, H.U., Almashanu, S., Steel, G. et al.(2005) Functional consequences of PRODH missense mutations. American Journal of Human Genetics 76, 409-420.
25. Benes, F.M., Vincent, S.L., Alsterberg, G., Bird, E.D.&san Giovanni, J.P.(1992) Increased GABA-A receptor binding in superfi cial laminae in cingulate cortex of schizophrenic brain. Journal of Neuroscience 12, 924-929.
26. Berg, S.A.&Chambers, R.A.(2008) Accentuated behavioral sensitization to nicotine in the neonatal ventral hippocampal lesion model of schizophrenia. Neuropharmacology 54, 1201-1207.
27. Bertolino, A., Saunders, R.C., Mattay, V.S., Bachevalier, J., Frank, J.A.&Weinberger, D.R.(1997) Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: A proton magnetic resonance spectroscopic imaging study. Cerebral Cortex 7, 740-748.
28. Bertolino, A., Callicott, J.H., Elman, I. et al.(1998) Regionally specifi c neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biological Psychiatry 43, 641-648.
29. Bertolino, A., Roffman, J.L., Lipska, B.K., Van Gelderen, P., Olson, A.,&Weinberger, D.R.(1999) Postpubertal emergence of prefrontal neuronal defi cits and altered dopaminergic behaviors in rats with neonatal hippocampal lesions. Social Neuroscience Abstract 520, 8.
30. Bertolino, A., Breier, A., Callicott, J.H. et al.(2000) The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia. Neuropsychopharmacology 22, 125-132.
31. Black, M.D., Lister, S., Hitchcock, J.M., Giersbergen, P.&Sorensen, S.M.(1998) Neonatal hippocampal lesion model of schizophrenia in rats: sex differences and persistence of effects into maturity. Drugs and Developmental Research 43, 206-213.
32. Black, M.D., Selk, D.E., Hitchcock, J.M., Wetttstein, J.G.&Sorensen, S.M.(1999) On the effect of neonatal nitric oxide synthase inhibition in rats: a potential neurodevelopmental model of schizophrenia. Neuropharmacology 38, 1299-1306.
33. Bloom, F.E.(1993) Advancing a neurodevelopmental origin of schizophrenia. Archives of General Psychiatry 50, 224-227.
34. Bogerts, B., Ashtar, M., Degreef, G., Alvir, J.M.J., Bilder, R.M.&Lieberman, J.A.(1990) Reduced temporal limbic structure volumes on magnetic resonance images in fi rst-episode schizophrenia . Psychiatric Research Neuroimaging 35, 1-13.
35. Boksa, P.&El-Khodor, B.F.(2003) Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models: possible implications for schizophrenia and other disorders . Neuroscience and Biobehavioral Review 27, 91-101.
36. Brake, W.G., Sullivan, R.M., Flores, G., Srivastava, L.&Gratton, A.(1999) Neonatal ventral hippocampal lesions attenuate the nucleus accumbens dopamine response to stress: an electrochemical study in the rat. Brain Research 831, 25-32.
37. Breier, A., Su, T.P., Saunders, R. et al.(1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proceedings of the National Academy of Sciencs USA 94, 2569-2574.
38. Callicott, J.H., Straub, R.E., Pezawas, L. et al.(2005) Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proceedings of the National Academy of Sciencs USA 102, 8627-8632.
39. Cannon, T.D., Hennah, W., van Erp, T.G. et al. (2005) Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short-and long-term memory. Archives of General Psychiatry 62, 1205-1213.
40. Carr, D.B.&Sesack, S.R.(1996) Hippocampal afferents to the rat prefrontal cortex: Synaptic targets and relation to dopaminergic terminals. Journal of Comparative Neurology 369, 1-15.
41. Chambers, R.A.&Taylor, J.R.(2004) Animal modeling dual diagnosis schizophrenia: sensitization to cocaine in rats with neonatal ventral hippocampal lesions. Biological Psychiatry 56, 308-316.
42. Chambers, R.A., Moore, J., McEvoy, J.P.&Levin, E.D.(1996) Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. Neuropsychopharmacology 15, 587-594.
43. Chambers, R.A., Jones, R.M., Brown, S.&Taylor, J.R.(2005) Natural reward-related learning in rats with neonatal ventral hippocampal lesions and prior cocaine exposure. Psychopharmacology (Berlin) 179, 470-478.
44. Chen, J., Lipska, B.K.&Weinberger, D.R.(2006) Genetic mouse models of schizophrenia: from hypothesis-based to susceptibility gene-based models. Biological Psychiatry 59, 1180-1188.
45. Chow, E.W., Watson, M., Young, D.A.&Bassett, A.S.(2006) Neurocognitive profi le in 22q11 deletion syndrome and schizophrenia . Schizophrenia Research 87, 270-278.
46. Cintra, L., Granados, L., Aguilar, A. et al. (1997) Effects of prenatal protein malnutrition on mossy fi bers of the hippocampal formation in rats of four age groups. Hippocampus 7, 184-191.
47. Clapcote, S.J., Lipina, T.V., Millar, J.K. et al.(2007) Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 54, 387-402.
48. Conrad, A.J., Abebe, T., Ron, A., Forsythe, S.&Scheibel, B. (1991) Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Archives of General Psychiatry 48, 413-417.
49. Conroy, S.K., Rodd, Z.&Chambers, R.A.(2007) Ethanol sensitization in a neurodevelopmental lesion model of schizophrenia in rats. Pharmacology, Biochemistry&Behavior 86, 386-394.
50. Corfas, G., Roy, K.&Buxbaum, J.D.(2004) Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nature Neuroscience 7, 575-580.
51. Costall, B.&Naylor, R.J.(1995) Animal neuropharmacology and its prediction of clinical response. In: Hirsch S.R.&Weinberger, D.R., eds. Schizophrenia . Oxford: Blackwell Science, pp. 401-424.
52. Cotter, D., Takei, N., Farrell, M. et al.(1995) Does prenatal exposure to infl uenza in mice induce pyramidal cell disarray in the dorsal hippocampus? Schizophrenia Research 16, 233-241.
53. Csernansky, J.G., Csernansky, C.A., Kogelman, L., Montgomery, E.M.&Bardgett, M.E.(1998) Progressive neurodegeneration after intracerebroventricular kainic acid administration in rats: implications for schizophrenia? Biological Psychiatry 44, 1143-1150.
54. Csernansky, J.G., Martin, M.V., Czeisler, B., Meltzer, M.A., Ali, Z.&Dong, H.(2006) Neuroprotective effects of olanzapine in a rat model of neurodevelopmental injury. Pharmacology, Biochemistry&Behavior 83, 208-213.
55. Dalman, C., Allebeck, P., Cullberg, J., Grunewald, C.&Koster, M.(1999) Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort. Archives of General Psychiatry 56, 234-240.
56. Davis, K.L., Kahn, R.S., Ko, G.&Davidson, M.(1991) Dopamine in schizophrenia: a review and reconceptualization. American Journal of Psychiatry 148, 1474-1486.
57. Dean, B., Karl, T., Pavey, G., Boer, S., Duffy, L.&Scarr, E.(2007) Increased levels of serotonin 2A receptors and serotonin transporter in the CNS of neuregulin 1 hypomorphic/mutant mice. Schizophrenia Research 99, 341-349.
58. DeLisi, L.E., Dauphinais, I.D.&Gershon, E.S.(1988) Perinatal complications and reduced size of brain limbic structures in familial schizophrenia. Schizophrenia Bulletin 14, 185-191.
59. Duan, X., Chang, J.H., Ge, S. et al.(2007) Disrupted-In - Schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell 130, 1146-1158.
60. Duncan, G.E., Sheitman, B.B.&Lieberman, J.A.(1999) An integrated view of pathophysiological models of schizophrenia. Brain Research Brain Research Review 29, 250-264.
61. Eastwood, S.L.&Harrison, P.J.(1995) Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience 69, 339-343.
62. Eastwood, S.L.&Harrison, P.J.(1998) Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia . Neuroscience 86, 437-448.
63. Eastwood, S.L., McDonald, B., Burnet, P.W., Beckwith, J.P., Kerwin, R.W.&Harrison, P.J.(1995) Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Brain Research Molecular Brain Research 29, 211-223.
64. Eastwood, S.L., Burnet, P.W.&Harrison, P.J.(1997) GluR2 glutamate receptor subunit fl ip and fl op isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase-polymerase chain reaction (RT-PCR) study. Brain Research Molecular Brain Research 44, 92-98.
65. Edelmann, L., Pandita, R.K.&Morrow, B.E.(1999) Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome. American Journal of Human Genetics 64, 1076-1086.
66. Egan, M.F., Goldberg, T.E., Kolachana, B.S. et al.(2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences USA 98, 6917-6922.
67. El-Khodor, B.F.&Boksa, P.(1997) Long-term reciprocal changes in dopamine levels in prefrontal cortex versus nucleus accumbens in rats born by Cesarean section compared to vaginal birth. Experimental Neurology 145, 118-129.
68. Ellenbroek, B.A., van den Kroonenberg, P.T.&Cools, A.R. (1998) The effects of an early stressful life event on sensorimotor gating in adult rats. Schizophrenia Research 30, 251-260.
69. Elvevag, B.&Goldberg, T.E.(2000) Cognitive impairment in schizophrenia is the core of the disorder. Critical Review of Neurobiology 14, 1-21 Emamian, E.S., Hall, D., Birnbaum, M.J., Karayiorgou, M.&Gogos, J.A.(2004) Convergent evidence for impaired AKT1 - GSK3beta signaling in schizophrenia. Nature Genetics 36, 131-137.
70. Emamian, E.S., Hall, D., Birnbaum, M.J., Karayiorgou, M. & Gogos, J.A.(2004) Convergent evidence for impaired AKT1 - GSK3beta signaling in schizophrenia. Nature Genetics 36, 131-137
71. Falkai, P.&Bogerts, B.(1986) Cell loss in the hippocampus of schizophrenics. European Archives of Psychiatry&Neurological Sciences 236, 154-161.
72. Fatemi, S.H., Emamian, E.S., Kist, D. et al.(1999) Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Molecular Psychiatry 4, 145-154.
73. Feldpausch, D.L., Needham, L.M., Stone, M.P. et al.(1998) The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations. Journal of Pharmacological&Experimental Therapeutics 286, 497-508.
74. Flores, G., Barbeau, D., Quirion, R.&Srivastava, L.K.(1996a) Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus. Journal of Neuroscience 16, 2020-2026.
75. Flores, G., Wood, G.K., Liang, J.J., Quirion, R.&Srivastava, L.K. (1996b) Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex. Journal of Neuroscience 16, 7366-7375.
76. Francis, D., Diorio, J., Liu, D.&Meaney, M.J.(1999) Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science 286, 1155-1158.
77. Gambarana, C., Masi, F., Tagliamonte, A., Scheggi, S., Ghiglieri, O.&De Montis, M.G.(1999) A chronic stress that impairs reactivity in rats also decreases dopaminergic transmission in the nucleus accumbens: a microdialysis study. Journal of Neurochemistry 72, 2039-2046.
78. Gelowitz, D.L., Rakic, P., Goldman-Rakic, P.S.&Selemon, L.D. (2002) Craniofacial dysmorphogenesis in fetally irradiated nonhuman primates: implications for the neurodevelop mental hypothesis of schizophrenia. Biological Psychiatry 52, 716-720.
79. Gerber, D.J., Hall, D., Miyakawa, T. et al.(2003) Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proceedings of the National Academy of Sciencs USA 100, 8993-8998.
80. Glatt, S.J., Faraone, S.V.&Tsuang, M.T.(2003) Association between a functional catechol O - methyltransferase gene polymorphism and schizophrenia: Meta-analysis of case-control and family-based studies. American Journal of Psychiatry 160, 469-476.
81. Gogos, J.A.&Gerber, D.J.(2006) Schizophrenia susceptibility genes: emergence of positional candidates and future directions . Trends in Pharmacological Sciences 27, 226-233.
82. Gogos, J.A., Santha, M., Takacs, Z. et al.(1999) The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nature Genetics 21, 434-439.
83. Goldberg, T.E., Egan, M.F., Gscheidle, T. et al.(2003) Executive subprocesses in working memory: relationship to catechol-O - methyltransferase Val158Met genotype and schizophrenia. Archives of General Psychiatry 60, 889-896.
84. Gothelf, D., Eliez, S., Thompson, T. et al.(2005) COMT genotype predicts longitudinal cognitive decline and psycho sis in 22q11.2 deletion syndrome. Nature Neuroscience 8, 1500-1502.
85. Grecksch, G., Bernstein, H.G., Becker, A., Hollt, V.&Bogerts, B. (1999) Disruption of latent inhibition in rats with postnatal hippocampal lesions. Neuropsychopharmacology 20, 525-532.
86. Hahn, C.G., Wang, H.Y., Cho, D.S. et al.(2006) Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nature Medicine 12, 824-828.
87. Harris, L.W., Sharp, T., Gartlon, J. et al.(2003) Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism. European Journal of Neuroscience 18, 1706-1710.
88. Harrison, P.J. & Weinberger, D.R.(2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry 10, 40-68.
89. Hennah, W., Varilo, T., Kestilä, M. et al.(2003) Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Human Molecular Genetics 12, 3151-3159.
90. Hikida, T., Jaaro-Peled, H., Seshadri, S. et al.(2007) Dominant - negative DISC1 transgenic mice display schizophrenia - associated phenotypes detected by measures translatable to humans. Proceedings of the National Academy of Sciencs USA 104, 14501-14506.
91. Hornig, M., Weissenbock, H., Horscroft, N.&Lipkin, W.I.(1999) An infection-based model of neurodevelopmental damage. Proceedings of the National Academy of Sciencs USA 96, 12102-12107.
92. Horowitz, A., Shifman, S., Rivlin, N., Pisante, A.&Darvasi, A. (2005) A survey of the 22q11 microdeletion in a large cohort of schizophrenia patients. Schizophrenia Research 73, 263-267.
93. Hultman, C.M., Ohman, A., Cnattingius, S., Wieselgren, I.M.&Lindstrom, L.H.(1997) Prenatal and neonatal risk factors for schizophrenia. British Journal of Psychiatry 170, 128-133.
94. Huotari, M., Gogos, J.A., Karayiorgou, M. et al.(2002) Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-defi cient mice. European Journal of Neuroscience 15, 246-256.
95. Huotari, M., Garcia-Horsman, J.A., Karayiorgou, M., Gogos, J.A.&Mannisto, P.T.(2004) D-amphetamine responses in catechol - O-methyltransferase (COMT) disrupted mice. Psychopharmacology (Berlin) 172, 1-10.
96. Jacquet, H., Demily, C., Houy, E. et al.(2005) Hyperprolinemia is a risk factor for schizoaffective disorder. Molecular Psychiatry 10, 479-485.
97. Javitt, D.C.&Zukin, S.R.(1991) Recent advances in the phencyclidine model of schizophrenia. American Journal of Psychiatry 148, 1301-1308.
98. Jay, T.M., Glowinski, J.&Thierry, A.M.(1989) Selectivity of the hippocampal projection to the prelimbic area of the prefrontal cortex in the rat. Brain Research 505, 337-340.
99. Jentsch, J.D.&Roth, R.H.(1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20, 201-225.
100. Jeste, D.V.&Lohr, J.B.(1989) Hippocampal pathologic fi ndings in schizophrenia: a morphometric study. Archives of General Psychiatry 46, 1019-1024.
101. Johnston, M.V., Barks, J., Greenmyre, T.&Silverstein, F.(1988) Use of toxins to disrupt neurotransmitter circuitry in the developing brain. Progress in Brain Research 73, 425-446.
102. Kamiya, A., Kubo, K., Tomoda, T. et al.(2005) A schizophrenia - associated mutation of DISC1 perturbs cerebral cortex development . Nature Cellular Biology 7, 1067-1078.
103. Karayiorgou, M., Morris, M.A., Morrow, B. et al.(1995) Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proceedings of the National Academy of Sciencs USA 92, 7612-7616.
104. Karl, T., Duffy, L., Scimone, A., Harvey, R.P. & Schofield, P.R. (2007) Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. Genes Brain Behavior 6, 677-687.
105. Kendell, R.E.&Kemp, I.W.(1989) Maternal infl uenza in the etiology of schizophrenia. Archives of General Psychiatry 46, 878-882.
106. Kendler, K.S., MacLean, C.J., O'Neill et al.(1996) Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish study of high-density schizophrenia families. American Journal of Psychiatry 153, 1534-1540.
107. Kesby, J.P., Burne, T.H., McGrath, J.J.&Eyles, D.W.(2006) Developmental vitamin D defi ciency alters MK 801-induced hyperlocomotion in the adult rat: An animal model of schizophrenia . Biological Psychiatry 60, 591-596.
108. Kimber, W.L., Hsieh, P., Hirotsune, S. et al.(1999) Deletion of 150 kb in the minimal DiGeorge/velocardiofacial syndrome critical region in mouse. Human Molecular Genetics 8, 2229-2237.
109. Kirkpatrick, B., Conley, R.C., Kakoyannis, A., Reep, R.L.&Roberts, R.C.(1999) Interstitial cells of the white matter in the inferior parietal cortex in schizophrenia: An unbiased cell - counting study. Synapse 34, 95-102.
110. Koike, H., Arguello, P.A., Kvajo, M., Karayiorgou, M. & Gogos, J.A.(2006) Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. Proceedings of the National Academy of Sciencs USA 103, 3693-3697.
111. Krystal, J.H., Karper, L.P., Seibyl, J.P. et al.(1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry 51, 199-214.
112. Kvajo, M., McKellar, H., Arguello, P.A. et al.(2008) A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specifi c alterations in neuronal architecture and cognition. Proceedings of the National Academy of Sciencs USA 105, 7076-7081.
113. Lahti, A.C., Koffel, B., LaPorte, D.&Tamminga, C.A.(1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia . Neuropsychopharmacology 13, 9-19.
114. Lai, W.S., Xu, B.&Westphal, K.G.(2006) Akt1 defi ciency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning. Proceedings of the National Academy of Sciencs USA 103, 16906-16911.
115. Laruelle, M., Abi-Dargham, A., van Dyck, C.H. et al.(1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proceedings of the National Academy of Sciences USA 93, 9235-9240.
116. Law, A.J., Lipska, B.K., Weickert, C.S. et al.(2006) Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5'SNPs associated with the disease. Proceedings of the National Academy of Sciencs USA 103, 6747-6752.
117. Law, A.J., Kleinman, J.E., Weinberger, D.R.&Weickert, C.S. (2007) Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Human Molecular Genetics 16, 129-141.
118. Le Pen, G.&Moreau, J.L.(2002) Disruption of prepulse inhibition of startle refl ex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology 27, 1-11.
119. Lee, C.J., Binder, T., Lipska, B.K. et al.(1998) Neonatal ventral hippocampal lesions produce an elevation of ??- FosB-like protein(s) in the rodent neocortex. Social Neuroscience Abstracts 24, 489.
120. Letts, V.A., Kang, M.G., Mahaffey, C.L. et al.(2003) Phenotypic heterogeneity in the stargazin allelic series. Mammalian Genome 14, 506-513.
121. Lewis, P., Patel, A.&Balazs, R.(1979) Effect of undernutrition on cell generation in the adult rat brain. Brain Research 168, 186-189.
122. Li, W., Zhou, Y., Jentsch, J.D. et al.(2007) Specifi c developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proceedings of the National Academy of Sciencs USA 104, 18280-18285.
123. Lieberman, J.A., Sheitman, B.B.&Kinon, B.J.(1997) Neurochemical sensitization in the pathophysiology of schizophrenia: defi cits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 17, 205-229.
124. Lillrank, S.M., Lipska, B.K.&Weinberger, D.R.(1995) Neurodevelopmental animal models of schizophrenia. Clinical Neuroscience 3, 98-104.
125. Lipska, B.K., Jaskiw, G.E.&Weinberger, D.R.(1993) Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal hippocampal damage: A potential animal model of schizophrenia. Neuropsychopharmacology 9, 67-75.
126. Lipska, B.K.&Weinberger, D.R.(1993) Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat. Developmental Brain Research 75, 13-22.
127. Lipska, B.K.&Weinberger, D.R.(1994a) Subchronic treatment with haloperidol or clozapine in rats with neonatal excitotoxic hippocampal damage. Neuropsychopharmacology 10, 199-205.
128. Lipska, B.K.&Weinberger, D.R.(1994b) Gonadectomy does not prevent novelty-or drug-induced hyperresponsiveness in rats with neonatal excitototxic hippocampal damage. Developmental Brain Research 78, 253-258.
129. Lipska, B.K.&Weinberger, D.R.(1995) Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats. Proceedings of the National Academy of Sciencs USA 92, 8906-8910.
130. Lipska, B.K.&Weinberger, D.R.(2000) To model a psychiatric disorder in animals: Schizophrenia as a reality test. Neuropsychopharmacology 23, 223-239.
131. Lipska, B.K., Chrapusta, S.J., Egan, M.F.&Weinberger, D.R. (1995) Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild chronic stress and haloperidol treatment. Synapse 20, 125-130.
132. Lipska, B.K., Al-Amin, H.A.&Weinberger, D.R.(1998a) Excitotoxic lesions of the rat medial prefrontal cortex: effects on abnormal behaviors associated with neonatal hippocampal damage. Neuropsychopharmacology 19, 451-464.
133. Lipska, B.K., Khaing, Z.Z., Lerman, D.N.&Weinberger, D.R. (1998b) Neonatal damage of the rat ventral hippocampus reduces expression of a dopamine transporter. Social Neurosciences Abstracts 24, 365.
134. Lipska, B.K., Halim, N.D., Segal, P.N.&Weinberger, D.R.(2002) Effects of reversible inactivation of the neonatal ventral hippocampus on behavior in the adult rat. Journal of Neuroscience 22, 2835-2842.
135. Lipska, B.K., Luu, S., Halim, N.D.&Weinberger, D.R.(2003) Behavioral effects of neonatal and adult excitotoxic lesions of the mediodorsal thalamus in the adult rat. Behavioural Brain Research 141, 105-111.
136. Lipska, B.K., Peters, T., Halim, N. et al.(2006) Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. Human Molecular Genetics 15, 1245-1258.
137. Liu, H., Heath, S.C., Sobin, C. et al.(2002) Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proceedings of the National Academy of Sciencs USA 99, 3717-3722.
138. Lohr, J.B.&Bracha, S.(1989) Can schizophrenia be related to prenatal exposure to alcohol? Some speculations. Schizophrenia Bulletin 15, 595-603.
139. Long, J.M., LaPorte, P., Merscher, S. et al.(2006) Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome. Neurogenetics 7, 247-257.
140. Mathe, J.M., Nomikos, G.G., Schilstrom, B.&Svensson, T.H. (1998) Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens. Journal of Neuroscience Research 51, 583-592.
141. McDonald-McGinn, D.M., Tonnesen, M.K., Laufer-Cahana et al. (2001) Phenotype of the 22q11.2 deletion in individuals identifi ed through an affected relative: cast a wide FISHing net! Genetics in Medicine 3, 23-29.
142. McNiel, T.F.(1988) Obstetric factors and perinatal injuries. In; Tsuang, M.T.&Simpson, J.C., eds. Handbook of Schizophrenia, 3. Nosology, Epidemiology and Genetic . Amsterdam: Elsevier, pp. 319-344.
143. Mednick, S.A., Machon, R.A., Huttunen, M.O.&Bonett, D. (1988) Adult schizophrenia following prenatal exposure to infl uenza epidemic. Archives of General Psychiatry 45, 189-192.
144. Meng, Z.H., Feldpaush, D.L.&Merchant, K.M.(1998) Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats. Brain Research Molecular Brain Research 61, 39-50.
145. Meyer, U., Nyffeler, M., Schwendener, S., Knuesel, I., Yee, B.K.&Feldon, J.(2008) Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dys function after in utero immune challenge. Neuropsychopharmacology 33, 441-456.
146. Millar, J.K., Wilson-Annan, J.C., Anderson, S. et al.(2000) Disruption of two novel genes by a translocation co-segregating with schizophrenia. Human Molecular Genetics 9, 1415-1423.
147. Millar, J.K., Pickard, B.S., Mackie, S. et al.(2005) DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310, 1187-1191.
148. Mintz, M., Gigi, A., Shohami, D.&Myslobodsky, M.S.(1999) Effects of prenatal exposure to gamma rays on circling and activity behavior in prepubertal and postpubertal rats. Behavioural Brain Research 98, 45-51.
149. Miyakawa, T., Leiter, L.M., Gerber, D.J. et al.(2003) Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proceedings of the National Academy of Sciencs USA 100, 8987-8992.
150. Moghaddam, B., Adams, B., Verma, A.&Daly, D.(1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. Journal of Neuroscience 17, 2921-2927.
151. Moghaddam, B.&Adams, B.(1998) Reversal of phencyclidine effects by group II metabotropic glutamate receptor agonist in rats. Science 281, 1349-1352.
152. Montgomery, E.M., Bardgett, M.E., Lall, B., Csernansky, C.A.&Csernansky, J.G.(1999) Delayed neuronal loss after administration of intracerebroventricular kainic acid to preweanling rats. Brain Research Developmental Brain Research 112, 107-116.
153. Moore, H., Jentsch, J.D., Ghajarnia, M., Geyer, M.A.&Grace, A.A.(2006) A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biological Psychiatry 60, 253-264.
154. Morris, JA, Kandpal, G, Ma, L,&Austin, CP(2003) DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Human Molecular Genetics 12, 1591-1608.
155. Mukai, J., Liu, H., Burt, R.A. et al.(2004) Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nature Genetics 36, 725-731.
156. Murase, S., Mathe, J.M., Grenhoff, J.&Svensson, T.H.(1993) Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on fi ring pattern related to anatomical localization. Journal of Neural Transmission Genetics Section 91, 13-25.
157. Murphy, K.C., Jones, L.A.&Owen, M.J.(1999) High rates of schizophrenia in adults with velo-cardio-facial syndrome. Archives of General Psychiatry 56, 940-945.
158. Murray, R.M.&Lewis, S.W.(1987) Is schizophrenia a neurodevelopmental disorder? British Medical Journal 295, 681-682.
159. Newton-Cheh, C.&Hirschhorn, J.N.(2005) Genetic association studies of complex traits: design and analysis issues. Mutation Research 573, 54-69.
160. O'Callaghan, E., Sham, P., Takei, N., Glover, G.&Murray, R.M. (1991) Schizophrenia after prenatal exposure to 1957 A2 infl uenza epidemic. Lancet 337, 248-1250.
161. O'Donnell, P.&Grace, A.A.(1998) Phencyclidine interferes with the hippocampal gating of nucleus accumbens neuronal activity in vivo . Neuroscience 87, 823-830.
162. O'Donnell, P., Lewis, B.L., Weinberger, D.R.&Lipska, B.K. (2002) Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons. Cerebral Cortex 12, 975-982.
163. Olney, J.W.&Farber, N.B.(1995) Glutamate receptor dysfunction and schizophrenia. Archives of General Psychiatry 52, 998-1007.
164. O'Tuathaigh, C.M., O'Sullivan, G.J., Kinsella, A. et al.(2006) Sexually dimorphic changes in the exploratory and habituation profi les of heterozygous neuregulin-1 knockout mice. Neuroreport 17, 79-83.
165. O'Tuathaigh, C.M., Babovic, D., O'Meara, G., Clifford, J.J., Croke, D.T.&Waddington, JL(2007a) Susceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour. Neuroscience Biobehavioral Review 31, 60-78.
166. O'Tuathaigh, C.M., Babovic, D., O'Sullivan, G.J. et al.(2007b) Phenotypic characterization of spatial cognition and social behavior in mice with " knockout " of the schizophrenia risk gene neuregulin 1. Neuroscience 147, 18-27.
167. O'Tuathaigh, C.M., O'Connor, A.M., O'Sullivan, G.J. et al. (2007c) Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous " knockout " of the schizophrenia risk gene neuregulin-1. Progress in Neuropsychopharmacology and Biological Psychiatry 32, 462-466.
168. Palmer, A.A., Printz, D.J., Butler, P.D., Dulawa, S.C.&Printz, M.P.(2004) Prenatal protein deprivation in rats induces changes in prepulse inhibition and NMDA receptor binding. Brain Research 996, 193-201.
169. Papaleo, F., Crawley, J.N., Song, J. et al.(2008) Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. Journal of Neuroscience 28, 8709-8723.
170. Paterlini, M., Zakharenko, S.S., Lai, W.S. et al.(2005) Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nature Neuroscience 8, 1586-1594.
171. Patil, S.T., Zhang, L., Martenyi, F. et al.(2007) Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nature Medicine 13, 1102-1107.
172. Paylor, R., Glaser, B., Mupo, A. et al.(2006) Tbx1 haploinsuffi - ciency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proceedings of the National Academy of Sciencs USA 103, 7729-7734.
173. Pearce, B.D.(2001) Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms. Molecular Psychiatry 6, 634-646.
174. Pletnikov, M.V., Ayhan, Y., Nikolskaia, O. et al.(2007) Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia . Molecular Psychiatry 13, 173-186.
175. Powell, K.J., Binder, T.L., Hori, S. et al.(2006) Neonatal ventral hippocampal lesions produce an elevation of ?FosB-like protein(s) in the rodent neocortex. Neuropsychopharmacology 31, 700-711.
176. Pritchard, J.K.&Cox, N.J.(2002) The allelic architecture of human disease genes: common disease-common variant...or not? Human Molecular Genetics 11, 2417-2423.
177. Pulver, A.E., Nestadt, G., Goldberg, R. et al.(1994) Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. Journal of Nervous and Mental Diseases 182, 476-478.
178. Qin, Z.H., Zhang, S.P.&Weiss, B.(1994) Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain. Brain Research and Molecular Brain Research 21, 293-302.
179. Rajakumar, N., Williamson, P.C., Stoessl, J.A.&Flumerfelt, B.A. (1996) Neurodevelopmental pathogenesis of schizophrenia. Social Neuroscience Abstracts 22, 1187.
180. Raux, G., Bumsel, E., Hecketsweiler, B. et al.(2007) Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Human Molecular Genetics 16, 83-91.
181. Rebbeck, T.R., Spitz, M.&Wu, X.(2004) Assessing the function of genetic variants in candidate gene association studies. Nature Review Genetics 5, 589-597.
182. Renick, S.E., Kleven, D.T., Chan, J. et al.(1999) The mammalian brain high-affi nity L-proline transporter is enriched preferentially in synaptic vesicles in a subpopulation of excitatory nerve terminals in rat forebrain. Journal of Neuroscience 19, 21-33.
183. Richtand, N.M., Taylor, B., Welge, J.A. et al.(2006) Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions. Neuropsychopharmacology 31, 77-89.
184. Rimer, M., Barrett, D.W., Maldonado, M.A., Vock, V.M.&Gonzalez-Lima, F.(2005) Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition. Neuroreport 16, 271-275.
185. Roffman, J.L., Lipska, B.K., Bertolino, A. et al.(2000) Local and downstream effects of excitotoxic lesions in the rat medial prefrontal cortex on in vivo 1 H-MRS signals. Neuropsychopharmacology 22, 430-439.
186. Rott, R., Herzog, S., Fleischer, B. et al.(1985) Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science 228, 755-756.
187. Roy, K., Murtie, J.C., El-Khodor, B.F. et al.(2007) Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders . Proceedings of the National Academy of Sciencs USA 104, 8131-8136.
188. Rueter, L.E., Ballard, M.E., Gallagher, K.B., Basso, A.M., Curzon, P. & Kohlhaas, K.L.(2004) Chronic low dose risperidone and clozapine alleviate positive but not negative symptoms in the rat neonatal ventral hippocampal lesion model of schizophrenia. Psychopharmacology (Berlin) 176, 312-319.
189. Sams-Dodd, F., Lipska, B.K.&Weinberger, D.R.(1997) Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and defi cits in social behaviour in adulthood. Psychopharmacology 132, 303-310.
190. Saunders, R.C., Kolachana, B.S., Bachevalier, J.&Weinberger, D.R.(1998) Neonatal lesions of the temporal lobe disrupt prefrontal cortical regulation of striatal dopamine. Nature 393, 169-171.
191. Scheibel, A.B.&Kovelman, J.A.(1981) Disorientation of the hippocampal pyramidal cell and its processes in the schizophrenic patient. Biological Psychiatry 16, 101-102.
192. Schroeder, H., Grecksch, G., Becker, A., Bogerts, B.&Höllt, V. (1999) Alterations of the dopaminergic and glutamatergic neurotransmission in adult rats with postnatal ibotenic acid hippocampal lesion. Psychopharmacology 145, 61-66.
193. Scolnick, E.M.(2006) Mechanisms of action of medicines for schizophrenia and bipolar illness: status and limitations. Biological Psychiatry 59, 1039-1045.
194. Sebat, J., Lakshmi, B., Malhotra, D. et al.(2007) Strong association of de novo copy number mutations with autism. Science 316, 445-449.
195. Selemon, L.D., Wang, L., Nebel, M.B., Csernansky, J.G., Goldman-Rakic, P.S.&Rakic, P.(2005) Direct and indirect effects of fetal irradiation on cortical gray and white matter volume in the macaque. Biological Psychiatry 57, 83-90.
196. Sesack, S.R., Hawrylak, V.A., Matus, C., Guido, M.A.&Levey, A.I.(1998) Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. Journal of Neuroscience 18, 2697-2708.
197. Shi, L., Fatemi, S.H., Sidwell, R.W.&Patterson, P.H.(2003) Maternal infl uenza infection causes marked behavioral and pharmacological changes in the offspring. Journal of Neuro_ science 23, 297-302.
198. Sobin, C., Kiley-Brabeck, K., Daniels, S. et al.(2005) Neuropsychological characteristics of children with the 22q11 Deletion Syndrome: a descriptive analysis. Child Neuropsychology 11, 39-53.
199. Solbrig, M.V., Koob, G.F.&Parsons, L.H. et al.(2000) Neurotrophic factor expression after CNS viral injury produces enhanced sensitivity to psychostimulants: potential mechanism for addiction vulnerability. Journal of Neuroscience 20, RC104.
200. Spanagel, R.&Weiss, F.(1999) The dopamine hypothesis of reward: past and current status. Trends in Neuroscience 22, 521-527.
201. Stark, K.L., Xu, B., Bagchi, A. et al.(2008) Altered brain micro- RNA biogenesis in mice defi cient for the 22q11 region contributes to behavioral and neuronal defi cits. Nature Genetics 40, 751-760.
202. Stefansson, H., Sigurdsson, E., Steinthorsdottir, V. et al.(2002) Neuregulin 1 and susceptibility to schizophrenia. American Journal of Human Genetics 71, 877-892.
203. Suddath, R.L., Christisin, G.W., Torrey, E.F., Casanova, M.&Weinberger, D.R.(1990) Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. New England Journal of Medicine 322, 789-794.
204. Sullivan, R., Wilson, D.A., Feldon, J. et al.(2006) The International Society for Developmental Psychobiology annual meeting symposium: Impact of early life experiences on brain and behavioral development. Developmental Psychobiology 48, 583-602.
205. Susser, E.S.&Lin, S.P.(1992) Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944 -?1945. Archives of General Psychiatry 49, 983-988.
206. Tabuchi, K., Blundell, J., Etherton, M.R. et al.(2007) A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318, 71-76.
207. Talamini, L.M., Koch, T., Ter Horst, G.J.&Korf, J.(1998) Methylazoxymethanol acetate-induced abnormalities in the entorhinal cortex of the rat; parallels with morphological fi ndings in schizophrenia. Brain Research 789, 293-306.
208. Tan, W., Wang, Y., Gold, B. et al.(2007) Molecular cloning of a brain-specifi c, developmentally regulated neuregulin 1 (NRG1) isoform and identifi cation of a functional promoter variant associated with schizophrenia. Journal of Biological Chemistry 282, 24343-24351.
209. Tseng, K.Y.&O'Donnell, P.(2004) Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. Journal of Neuroscience 24, 5131-5139.
210. Tseng K.Y.&O'Donnell, P.(2007) D2 dopamine receptors recruit a GABA component for their attenuation of excitatory synaptic transmission in the adult rat prefrontal cortex. Synapse 61, 843-850.
211. Tseng, K.Y., Lewis, B.L., Lipska, B.K., O'Donnell, P.(2007) Post - pubertal disruption of medial prefrontal cortical dopamine - glutamate interactions in a developmental animal model of schizophrenia. Biological Psychiatry 62, 730-738.
212. Tseng, K.Y., Chambers, R.A.&Lipska, B.K.(2009) The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia. Behavioural Brain Research 204, 295-305.
213. Uehara, T., Sumiyoshi, T., Matsuoka, T., Itoh, H.&Kurachi, M. (2007) Effect of prefrontal cortex inactivation on behavioral and neurochemical abnormalities in rats with excitotoxic lesions of the entorhinal cortex. Synapse 61, 391-400.
214. Vanderschuren, L.J., Schmidt, E.D., De Vries, T.J., Van Moorsel, C.A., Tilders, F.J.&Schoffelmeer, A.N.(1999) A single exposure to amphetamine is suffi cient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats. Journal of Neuroscience 19, 9579-9586.
215. Varty, G.B.&Higgins, G.A.(1995) Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacology 122, 15-26.
216. Verma, A.&Moghaddam, B.(1996) NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. Journal of Neuroscience 16, 373-379.
217. Volk, D.W.&Lewis, D.A.(2003) Effects of a mediodorsal thalamus lesion on prefrontal inhibitory circuitry: implications for schizophrenia. Biological Psychiatry 53, 385-389.
218. Waltrip, R.W. 2nd, Buchanan, R.W., Summerfeld, A. et al.(1995) Borna disease virus and schizophrenia. Psychiatric Research 56, 33-44.
219. Wan, R.-Q., Giovanni, A., Kafka, S.H.&Corbett, R.(1996) Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: behavioral and in vivo microdialysis studies. Behavioural Brain Research 78, 211-223.
220. Wan, R.Q. & Corbett, R.(1997) Enhancement of postsynaptic sensitivity to dopaminergic agonists induced by neonatal hippocampal lesions. Neuropsychopharmacology 16, 259-268.
221. Wan, R.Q., Hartman, H.&Corbett, R.(1998) Alteration of dopamine metabolites in CSF and behavioral impairments induced by neonatal hippocampal lesions. Physiological Behavior 65, 429-436.
222. Weinberger, D.R.(1986) The pathogenesis of schizophrenia: a neurodevelopmental theory. In: Nasrallah, H.A.&Weinberger, D.R., eds. The Neurology of Schizophrenia . Amsterdam: Elsevier, pp. 397-406.
223. Weinberger, D.R.(1987) Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry 44, 660-669.
224. Weinberger, D.R.(1999) Cell biology of the hippocampal formation in schizophrenia. Biological Psychiatry 45, 395-402.
225. Weinberger, D.R.&Lipska, B.K.(1995) Corticol maldevelopment anti-psychotic drugs, and schizophrenia: in search of common ground. Schizophrenia Research 16, 87-110.
226. Wiehahn, G.J., Bosch, G.P., du Preez, R.R., Pretorius, H.W., Karayiorgou, M.&Roos, J.L.(2004) Assessment of the frequency of the 22q11 deletion in Afrikaner schizophrenic patients. American Journal of Medical Genetics B Neuropsychiatric Genetics 129, 20-22.
227. Woerner, M.G., Pollack, M.&Klein, D.F.(1973) Pregnancy and birth complications in psychiatric patients: a comparison of schizophrenic and personality disorder patients with their siblings. Acta Psychiatrica Scandinavica 49, 712-721.
228. Wolf, M.E., White, F.J.&Hu, X.-T.(1993) Behavioral sensitization to MK-801 (dizocilpine): neurochemical and electrophysiological electrophysiological correlates in the mesoaccumbens dopamine system. Behavioral Pharmacolgy 4, 429-442.
229. Wong, H.A.C., Lipska, B.K., Likhodi, O. et al.(2005) Cortical gene expression in the neonatal ventral-hippocampal lesion model of schizophrenia. Schizophrenia Research 77, 261-270.
230. Woodin, M., Wang, P.P., Aleman, D., McDonald-McGinn, D., Zackai, E.&Moss, E.(2001) Neuropsychological profi le of children and adolescents with the 22q11.2 microdeletion. Genetic Medicine 3, 34-39.
231. Yavich, L., Forsberg, M.M., Karayiorgou, M., Gogos, J.A.&Männistö, P.T.(2007) Site-specifi c role of catechol-O-methyltransferase in dopamine overfl ow within prefrontal cortex and dorsal striatum. Journal of Neuroscience 27, 10196-10209.
232. Yonezawa, Y., Kuroki, T., Kawahara, T., Tashiro, N.&Uchimura, H.(1998) Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex. European Journal of Pharmacology 341, 45-56.
233. Zaharia, M.D., Kulczycki, J., Shanks, N., Meaney, M.J.&Anisman, H.(1996) The effects of early postnatal stimulation on Morris water-maze acquisition in adult mice: genetic and maternal factors. Psychopharmacology 128, 227-239.
234. Zuckerman, L., Rehavi, M., Nachman, R.&Weiner, I.(2003) Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia . Neuropsychopharmacology 28, 1778-1789.